Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AtriCure (ATRC) Equity Average (2016 - 2025)

Historic Equity Average for AtriCure (ATRC) over the last 15 years, with Q3 2025 value amounting to $470.5 million.

  • AtriCure's Equity Average rose 149.84% to $470.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $470.5 million, marking a year-over-year increase of 149.84%. This contributed to the annual value of $463.6 million for FY2024, which is 45.67% up from last year.
  • Per AtriCure's latest filing, its Equity Average stood at $470.5 million for Q3 2025, which was up 149.84% from $459.6 million recorded in Q2 2025.
  • AtriCure's 5-year Equity Average high stood at $486.1 million for Q4 2021, and its period low was $388.2 million during Q2 2021.
  • For the 5-year period, AtriCure's Equity Average averaged around $454.2 million, with its median value being $459.6 million (2025).
  • As far as peak fluctuations go, AtriCure's Equity Average surged by 6929.04% in 2021, and later tumbled by 670.25% in 2022.
  • Quarter analysis of 5 years shows AtriCure's Equity Average stood at $486.1 million in 2021, then decreased by 6.7% to $453.5 million in 2022, then grew by 2.42% to $464.5 million in 2023, then fell by 0.32% to $463.0 million in 2024, then increased by 1.62% to $470.5 million in 2025.
  • Its Equity Average was $470.5 million in Q3 2025, compared to $459.6 million in Q2 2025 and $457.8 million in Q1 2025.